John Hancock Classic Value Fund Class C (JCVCX)
| Fund Assets | 519.35M |
| Expense Ratio | 1.90% |
| Min. Investment | $1,000 |
| Turnover | 13.00% |
| Dividend (ttm) | 6.83 |
| Dividend Yield | 36.22% |
| Dividend Growth | -43.62% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 19, 2025 |
| Previous Close | 18.52 |
| YTD Return | 1.78% |
| 1-Year Return | 7.91% |
| 5-Year Return | 50.50% |
| 52-Week Low | 14.79 |
| 52-Week High | 19.24 |
| Beta (5Y) | n/a |
| Holdings | 35 |
| Inception Date | Nov 11, 2002 |
About JCVCX
John Hancock Classic Value Fund Class C is an open-end equity mutual fund managed by John Hancock Investment Management, with co-management by Pzena Investment Management. The fund primarily seeks long-term capital growth by investing at least 80% of its net assets in the equity securities of U.S. companies, emphasizing large-cap firms considered undervalued relative to their intrinsic worth based on future earnings and cash flow projections. It employs a value investing strategy, targeting shares with valuation ratios such as price-to-book below the market average, and benchmarks its performance against the Russell 1000 Value Index and the broader Russell 1000 Index. The portfolio is diversified across multiple sectors and may allocate up to 20% of assets to foreign equities, including depositary receipts. Notably, the fund integrates fundamental analysis and proprietary research in its stock selection process and may give preference to companies demonstrating socially conscious business practices and environmental responsibility. Designed for investors seeking potential value-driven appreciation, the fund plays a significant role within the large value mutual fund category, offering sector diversification and exposure to established U.S. companies.
Performance
JCVCX had a total return of 7.91% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.75%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FVLCX | Fidelity | Fidelity Advisor Value Leaders Fund | 1.90% |
| FSLVX | Fidelity | Fidelity Stock Selector Large Cap Value Fund | 0.83% |
| SWLVX | Schwab | Schwab U.S. Large-Cap Value Index Fund | 0.03% |
| FVLIX | Fidelity | Fidelity Advisor Value Leaders Fund | 0.90% |
| FSCZX | Fidelity | Fidelity Advisor Stock Selector Large Cap Value Fund - Class Z | 0.72% |
Top 10 Holdings
44.03% of assets| Name | Symbol | Weight |
|---|---|---|
| CVS Health Corporation | CVS | 5.57% |
| Citigroup Inc. | C | 4.73% |
| Humana Inc. | HUM | 4.66% |
| Wells Fargo & Company | WFC | 4.47% |
| Baxter International Inc. | BAX | 4.38% |
| Dollar General Corporation | DG | 4.25% |
| Magna International Inc. | MG | 4.19% |
| Capital One Financial Corporation | COF | 4.18% |
| Fresenius Medical Care AG | FMS | 4.01% |
| Bank of America Corporation | BAC | 3.60% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $6.82782 | Dec 22, 2025 |
| Dec 20, 2024 | $12.10988 | Dec 23, 2024 |
| Dec 19, 2023 | $1.94361 | Dec 20, 2023 |
| Dec 19, 2022 | $5.69713 | Dec 20, 2022 |
| Dec 18, 2020 | $0.21927 | Dec 21, 2020 |
| Dec 13, 2019 | $1.25979 | Dec 16, 2019 |